Literature DB >> 24813411

Acute and maintenance treatments for bipolar depression.

Terence A Ketter1.   

Abstract

Patients with bipolar disorder are symptomatic about half of the time, experiencing depression more often than mania/hypomania. Because patients usually seek treatment during a depressive episode (rather than a manic episode), bipolar depression is commonly misdiagnosed as unipolar depression. Providing an accurate and timely bipolar depression diagnosis is critical for the proper treatment of the patient. Some FDA-approved treatments are helpful during acute and maintenance phases of therapy, but there is a significant unmet need for effective bipolar depression treatments with favorable side-effect profiles. Newer agents offer the promise of improvements in tolerability, but additional research is needed to actualize this promise into better treatments for patients struggling with bipolar depression. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813411     DOI: 10.4088/JCP.13010tx2c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2.

Authors:  Martha Sajatovic; Ruth Ross; Susan N Legacy; Matthew Byerly; John M Kane; Faith DiBiasi; Heather Fitzgerald; Christoph U Correll
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-08       Impact factor: 2.570

2.  Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy.

Authors:  Gioia Baggiani; Luca Ambrosiani; Pierfranco Trincas; Caterina Burrai; Alberto Bocchetta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2018-10-30

3.  Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells.

Authors:  Tao Song; Hui Li; Zhiliang Tian; Chaojiu Xu; Jingfang Liu; Yong Guo
Journal:  Onco Targets Ther       Date:  2015-08-20       Impact factor: 4.147

4.  Pharmacotherapy of bipolar disorder with quetiapine: a recent literature review and an update.

Authors:  Ather Muneer
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.